[Form 4] PennyMac Financial Services, Inc. Insider Trading Activity

Rhea-AI Filing Summary

PennyMac Financial Services (PFSI): A reporting officer/director filed a Form 4 for transactions on 11/05/2025. The filer exercised 4,318 stock options at $11.28 per share and sold 4,318 shares at a weighted average price of $126.09, with trades ranging from $126.00 to $126.45. Following the transactions, the filer reported 19,056 shares directly (restricted stock units scheduled to settle in shares upon vesting), plus indirect holdings of 15,337 shares via The Jones Family Trust and 450,000 shares via GR Family Investments LLC. The filer also reports multiple nonstatutory stock option grants outstanding, including 23,453 remaining at a $11.28 exercise price, with other grants expiring between 2026 and 2035.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones Doug

(Last) (First) (Middle)

C/O PENNYMAC FINANCIAL SERVICES, INC.

3043 TOWNSGATE ROAD

(Street)

WESTLAKE VILLAGE CA 91361

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PennyMac Financial Services, Inc. [ PFSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Director, President & CMBO

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2025		M		4,318	A	$11.28	23,374(1)	D
Common Stock	11/05/2025		S		4,318	D	$126.09(2)	19,056(3)	D
Common Stock								15,337	I	The Jones Family Trust
Common Stock								450,000	I	GR Family Investments LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Nonstatutory Stock Option (Right to Buy)	$11.28	11/05/2025		M			4,318	03/07/2017	03/06/2026	Common Stock	4,318(4)	$0	23,453	D
Nonstatutory Stock Option (Right to Buy)	$18.05							03/06/2018	03/05/2027	Common Stock	34,626(5)		34,626	D
Nonstatutory Stock Option (Right to Buy)	$24.4							03/09/2019	03/08/2028	Common Stock	26,467(6)		26,467	D
Nonstatutory Stock Option (Right to Buy)	$22.92							03/15/2020	03/14/2029	Common Stock	27,744(7)		27,744	D
Nonstatutory Stock Option (Right to Buy)	$59.68							12/14/2020	12/13/2030	Common Stock	54,024(8)		54,024	D
Nonstatutory Stock Option (Right to Buy)	$35.03							02/26/2021	02/25/2030	Common Stock	30,366(9)		30,366	D
Nonstatutory Stock Option (Right to Buy)	$58.85							02/25/2022	02/24/2031	Common Stock	29,566(10)		29,566	D
Nonstatutory Stock Option (Right to Buy)	$57.1							02/23/2023	02/22/2032	Common Stock	54,063(11)		54,063	D
Nonstatutory Stock Option (Right to Buy)	$60.74							02/24/2024	02/23/2033	Common Stock	25,724(12)		25,724	D
Nonstatutory Stock Option (Right to Buy)	$84.93							03/01/2025(13)	02/28/2034	Common Stock	27,044(13)		27,044	D
Nonstatutory Stock Option (Right to Buy)	$101.76							02/14/2026(14)	02/13/2035	Common Stock	21,456(14)		21,456	D

Explanation of Responses:

1. The reported amount consists of 19,056 restricted stock units and 4,318 shares of Common Stock. The restricted stock units are to be settled in an equal number of shares of Common Stock upon vesting.

2. The price reported is the weighted average price of multiple transactions ranging from $126.00 to $126.45. The reporting person hereby undertakes to provide upon request to the SEC, the Issuer or a security holder of the Issuer the number of Common Stock and the prices at which the transactions were effected.

3. The reported amount consists of 19,056 restricted stock units which are to be settled in an equal number of shares of Common Stock upon vesting.

4. This nonstatutory stock option to purchase 27,771 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of March 7, 2017, 2018 and 2019, subject to the Reporting Person's committed service through each date.

5. This nonstatutory stock option to purchase 34,626 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of March 6, 2018, 2019 and 2020, subject to the Reporting Person's continued service through each date.

6. This nonstatutory stock option to purchase 26,467 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of March 9, 2019, 2020 and 2021, subject to the Reporting Person's continued service through each date.

7. This nonstatutory stock option to purchase 27,744 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of March 15, 2020, 2021 and 2022, subject to the Reporting Person's continued service through each date.

8. This nonstatutory stock option to purchase 54,024 shares of Common Stock of the Issuer is fully vested but subject to certain transfer restrictions that will lapse in one-third increments on each of December 14, 2020, 2021 and 2022, subject to the Reporting Person's continued service through each date.

9. This nonstatutory stock option to purchase 30,366 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of February 26, 2021, 2022 and 2023, subject to the Reporting Person's continued service through each date.

10. This nonstatutory stock option to purchase 29,566 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of February 25, 2022, 2023 and 2024, subject to the Reporting Person's continued service through each date.

11. This nonstatutory stock option to purchase 54,063 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of February 23, 2023, 2024 and 2025, subject to the Reporting Person's continued service through each date.

12. This nonstatutory stock option to purchase 25,724 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of February 24, 2024, 2025 and 2026, subject to the Reporting Person's continued service through each date.

13. This nonstatutory stock option to purchase 27,044 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of March 1, 2025, 2026 and 2027, subject to the Reporting Person's committed service through each date.

14. This nonstatutory stock option to purchase 21,456 shares of Common Stock of the Issuer will vest as to one-third of the optioned shares on each of February 14, 2026, 2027 and 2028, subject to the Reporting Person's continued service through each date.

	/s/ Derek W. Stark, attorney-in-fact for Mr. Jones	11/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PFSI’s insider report on the latest Form 4?

An option exercise of 4,318 shares at $11.28 per share and a sale of 4,318 shares at a $126.09 weighted average on 11/05/2025.

What price range were the PFSI shares sold at?

Sales were executed between $126.00 and $126.45, with a weighted average of $126.09.

How many PFSI shares does the insider hold directly after the transactions?

19,056 shares directly, reported as restricted stock units that will settle in shares upon vesting.

What indirect PFSI holdings were disclosed?

15,337 shares held via The Jones Family Trust and 450,000 shares via GR Family Investments LLC.

What options remain outstanding for the insider?

Nonstatutory stock options remain outstanding, including 23,453 at a $11.28 exercise price, with other grants expiring from 2026 to 2035.

What roles does the reporting person hold at PFSI?

Director and Officer (Director, President & CMBO).